BANK OF AMERICA CORP /DE/ - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,606,725
+112.4%
154,900
+28.7%
0.00%
Q2 2023$2,169,139
-23.5%
120,374
-31.8%
0.00%
Q1 2023$2,834,156
+24.8%
176,473
+42.2%
0.00%
Q4 2022$2,270,426
+94.4%
124,067
+108.7%
0.00%
Q3 2022$1,168,000
+15.3%
59,457
+9.5%
0.00%
Q2 2022$1,013,000
-52.9%
54,286
-44.6%
0.00%
Q1 2022$2,150,000
+11.1%
97,934
+43.8%
0.00%
Q4 2021$1,935,000
+689.8%
68,097
+485.9%
0.00%
Q3 2021$245,000
-0.8%
11,622
-11.3%
0.00%
Q2 2021$247,000
+31.4%
13,109
+6.4%
0.00%
Q1 2021$188,000
-30.9%
12,320
-36.2%
0.00%
Q4 2020$272,000
-14.5%
19,320
-4.9%
0.00%
Q3 2020$318,000
-12.9%
20,320
-2.5%
0.00%
Q2 2020$365,000
+162.6%
20,834
+120.8%
0.00%
Q1 2020$139,000
-57.4%
9,436
-27.4%
0.00%
Q4 2019$326,000
+91.8%
12,998
+14.9%
0.00%
Q3 2019$170,000
-46.2%
11,308
-10.3%
0.00%
Q2 2019$316,000
-53.7%
12,613
-57.9%
0.00%
Q1 2019$682,000
+281.0%
29,944
+404.8%
0.00%
Q4 2018$179,000
+397.2%
5,932
+377.2%
0.00%
Q3 2018$36,0001,2430.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders